Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 310 participants.
Also called NCT01448174
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose basic science
- Phase
- Phase 4
- Enrolled
- 310 participants
- Registry
-
NCT01448174
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Poland
- Registry status
- Completed
Technical summary
Registry record NCT01448174. Randomized; double masking; primary purpose basic science. Start 2011-10 (registry gives no type); primary completion 2014-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
- Condition
- Renal Failure Chronic Requiring Hemodialysis
- Condition
- Metabolic Syndrome
- Condition
- Diabetes Mellitus Type 2
- Condition
- Hyperlipidemia
- Intervention (Drug)
- Atorvastatin
- Lead sponsor
- Poznan University of Medical Sciences
Record details
- Record id
cardio:ct-nct01448174- Content hash
a1db61aac8be51bec6b5791b0fc3e1bb7735d0d9256e1a60feccc9337e1ad32d